No double standards for natural health products

November 14, 2011

Natural health products and medicinal foods should be subject to the same regulations as pharmaceutical drugs to ensure safety and efficacy, states an editorial in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/site/embargo/cmaj111739.pdf.

While pharmaceutical drugs are subject to rigorous evaluation and must provide significant evidence of their therapeutic effects and that the benefits outweigh risks, natural health products in Canada are not. Many contain active pharmacological substances that can have potent effects and interactions which should have warnings.

"The multibillion-dollar natural health products industry sells the perception that because its products are "natural," they must also be safe, such that comprehensive testing like that required for pharmaceuticals is not required," write guest author Dr. Stuart MacLeod with CMAJ editor Dr. Matthew Stanbrook and colleagues. "However, it is a near-universal truth that any substance that exerts a beneficial effect on a biological system will also have the potential for adverse effects."

Health Canada created the Natural Health Products Directorate 10 years ago, but the regulatory framework that governs it does not protect the consumer.

"All health claims for any product should be subject to a common set of regulations, starting with consistent and easily understood standards of evidence proportional to health risks and benefits," conclude the authors.

"Uniform regulations are the best way to protect consumers while still allowing choice."
-end-


Canadian Medical Association Journal

Related Pharmaceutical Drugs Articles from Brightsurf:

Novel method can efficiently create several 'building blocks' of pharmaceutical drugs
A class of organic compounds that form the backbone of several pharmaceuticals, alicyclic compounds, are difficult to synthesize.

Changes needed to prevent controversial pharmaceutical deals
New research from the University of East Anglia (UEA) recommends changes to the system which sees drug companies strike deals with competitors to stop them producing cheaper generic alternatives.

GARDP partners with Japanese pharmaceutical in pursuit of new antibiotics
The Global Antibiotic Research and Development Partnership (GARDP) has today announced an agreement with Daiichi Sankyo for GARDP to access and screen the Daiichi Sankyo chemical library.

The integrated catalysts can simplify pharmaceutical manufacturing
Prof. In Su Lee and his research team from POSTECH developed catalytic platforms based on metal organic frameworks.

Study: Pharmaceutical companies marketing stimulants to physicians
Results of a new study show that a large number of physicians in the US may have received marketing payments from pharmaceutical companies that produce stimulant medications.

3D printing with applications in the pharmaceutical industry
This achievement will have applications in the pharmaceutical industry, such as in the preparation of biocompatible biosensors based in gold, which have already been shown to be effective in the detection of carcinogenic cells and tumour biomarkers.

Turning wood into pharmaceutical ingredients 
Production of hazardous waste during drug manufacturing is a serious concern for the pharmaceutical industry.

New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.

Active pharmaceutical ingredients can persist in the environment
A study finds trace levels of medicines in drinking water from private wells.

Drug development stakeholders call for improved pharmaceutical testing
Published in Drug Discovery Today, 'Advancing Nonclinical Innovation and Safety in Pharmaceutical Testing' identifies the necessary steps that will lead to safer and more effective medicines, guided by a greater focus on human-based in vitro and in silico methods, which allow scientists to observe human cells, tissues, and biological processes, and their interaction with potential medications.

Read More: Pharmaceutical Drugs News and Pharmaceutical Drugs Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.